Literature DB >> 28478529

DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers.

Patricia S Muñoz1, Juan Segura-Aguilar2.   

Abstract

Alpha-synuclein (SNCA) oligomers have been reported to inhibit autophagy. Aminochrome-induced SNCA oligomers are neurotoxic, but the flavoenzyme DT-diaphorase prevents both their formation and their neurotoxicity. However, the possible protective role of DT-diaphorase against autophagy impairment by aminochrome-induced SNCA oligomers remains unclear. To test this idea, we used the cell line RCSN-3NQ7SNCA, with constitutive expression of a siRNA against DT-diaphorase and overexpression SNCA, and RCSN-3 as control cells. A significant increase in LC3-II expression was observed in RCSN-3 cells treated with 20 μM aminochrome and 10 μM rapamycin followed by a decrease in cell death compared to RCSN-3 cells incubated with 20 μM aminochrome alone. The incubation of RCSN-3NQ7SNCA cells with 20 μM aminochrome and 10 μM rapamycin does not change the expression of LC3-II in comparison with RCSN-3NQ7SNCA cells incubated with 20 μM aminochrome alone. The incubation of both cell lines preincubated with 100 nM bafilomycin and 20 μM aminochrome increases the level of LC3-II. Under the same conditions, cell death increases in both cell lines in comparison with cells incubated with 20 μM aminochrome. These results support the protective role of DT-diaphorase against SNCA oligomers-induced autophagy inhibition.

Entities:  

Keywords:  Alpha-synuclein; Aminochrome; Autophagy; Dopamine; Mitochondria; Neurodegeneration

Mesh:

Substances:

Year:  2017        PMID: 28478529     DOI: 10.1007/s12640-017-9747-4

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  46 in total

1.  Endoproteolytic activity of the proteasome.

Authors:  Chang-Wei Liu; Michael J Corboy; George N DeMartino; Philip J Thomas
Journal:  Science       Date:  2002-12-12       Impact factor: 47.728

2.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.

Authors:  A Abeliovich; Y Schmitz; I Fariñas; D Choi-Lundberg; W H Ho; P E Castillo; N Shinsky; J M Verdugo; M Armanini; A Ryan; M Hynes; H Phillips; D Sulzer; A Rosenthal
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

3.  A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition.

Authors:  Khan Shoeb Zafar; David Siegel; David Ross
Journal:  Mol Pharmacol       Date:  2006-06-21       Impact factor: 4.436

4.  Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations.

Authors:  Erin H Norris; Benoit I Giasson; Roberto Hodara; Shaohua Xu; John Q Trojanowski; Harry Ischiropoulos; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2005-04-06       Impact factor: 5.157

5.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

Authors:  M G Spillantini; R A Crowther; R Jakes; M Hasegawa; M Goedert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line.

Authors:  Irmgard Paris; Patricia Muñoz; Sandro Huenchuguala; Eduardo Couve; Laurie H Sanders; John Timothy Greenamyre; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Toxicol Sci       Date:  2011-04-06       Impact factor: 4.849

7.  Stable expression of short interfering RNA for DT-diaphorase induces neurotoxicity.

Authors:  Jorge Lozano; Patricia Muñoz; Beston F Nore; Susan Ledoux; Juan Segura-Aguilar
Journal:  Chem Res Toxicol       Date:  2010-09-20       Impact factor: 3.739

Review 8.  Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.

Authors:  Michael J Volles; Peter T Lansbury
Journal:  Biochemistry       Date:  2003-07-08       Impact factor: 3.162

9.  Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase.

Authors:  Y Xu; A H Stokes; R Roskoski; K E Vrana
Journal:  J Neurosci Res       Date:  1998-12-01       Impact factor: 4.164

Review 10.  The synucleins.

Authors:  Julia M George
Journal:  Genome Biol       Date:  2001-12-20       Impact factor: 13.583

View more
  10 in total

Review 1.  Neurotoxins as Preclinical Models for Parkinson's Disease.

Authors:  Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-01-08       Impact factor: 3.911

2.  Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease.

Authors:  Fillipe Mendes De Araújo; Annyta Fernandes Frota; Lívia Bacelar de Jesus; Ticiane Caribe Macedo; Lorena Cuenca-Bermejo; Consuelo Sanchez-Rodrigo; Kariny Maria Silva Ferreira; Juciele Valéria Ribeiro de Oliveira; Maria de Fatima Dias Costa; Juan Segura-Aguilar; Silvia Lima Costa; Maria Trinidad Herrero; Victor Diógenes Amaral Silva
Journal:  Cell Mol Neurobiol       Date:  2022-01-06       Impact factor: 5.046

3.  Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease.

Authors:  David Sulzer; Fabio A Zucca; Luigi Zecca
Journal:  Clin Pharmacol Transl Med       Date:  2019-05-06

4.  Novel Alpha-Synuclein Oligomers Formed with the Aminochrome-Glutathione Conjugate Are Not Neurotoxic.

Authors:  Sandro Huenchuguala; Birgitta Sjödin; Bengt Mannervik; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-10-20       Impact factor: 3.911

5.  Cellular Trafficking of Glutathione Transferase M2-2 Between U373MG and SHSY-S7 Cells is Mediated by Exosomes.

Authors:  Raúl Valdes; Alicia Armijo; Patricia Muñoz; Kjell Hultenby; Andres Hagg; Jose Inzunza; Ivan Nalvarte; Mukesh Varshney; Bengt Mannervik; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2021-02-08       Impact factor: 3.911

Review 6.  Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson's Disease and Intervention with Turmeric.

Authors:  Zuné Jansen van Rensburg; Shameemah Abrahams; Soraya Bardien; Colin Kenyon
Journal:  Mol Neurobiol       Date:  2021-08-23       Impact factor: 5.590

7.  Aminochrome Induces Irreversible Mitochondrial Dysfunction by Inducing Autophagy Dysfunction in Parkinson's Disease.

Authors:  Juan Segura-Aguilar; Sandro Huenchuguala
Journal:  Front Neurosci       Date:  2018-03-13       Impact factor: 4.677

Review 8.  Amburana cearensis: Pharmacological and Neuroprotective Effects of Its Compounds.

Authors:  Juliana Helena Castro E Silva; Rafael Short Ferreira; Erica Patricia Pereira; Suzana Braga-de-Souza; Monique Marylin Alves de Almeida; Cleonice Creusa Dos Santos; Arthur Morgan Butt; Elisabetta Caiazzo; Raffaele Capasso; Victor Diogenes Amaral da Silva; Silvia Lima Costa
Journal:  Molecules       Date:  2020-07-27       Impact factor: 4.411

Review 9.  On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease.

Authors:  Juan Segura-Aguilar
Journal:  Neural Regen Res       Date:  2017-06       Impact factor: 5.135

10.  Autophagy prevents hippocampal α-synuclein oligomerization and early cognitive dysfunction after anesthesia/surgery in aged rats.

Authors:  Ning Yang; Zhengqian Li; Dengyang Han; Xinning Mi; Miao Tian; Taotao Liu; Yue Li; Jindan He; Chongshen Kuang; Yiyun Cao; Lunxu Li; Cheng Ni; John Q Wang; Xiangyang Guo
Journal:  Aging (Albany NY)       Date:  2020-04-26       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.